MX2012002149A - Compuestos que contienen nitrogeno y composiciones farmaceuticas de los mismos para el tratamiento de fibrilacion auricular. - Google Patents

Compuestos que contienen nitrogeno y composiciones farmaceuticas de los mismos para el tratamiento de fibrilacion auricular.

Info

Publication number
MX2012002149A
MX2012002149A MX2012002149A MX2012002149A MX2012002149A MX 2012002149 A MX2012002149 A MX 2012002149A MX 2012002149 A MX2012002149 A MX 2012002149A MX 2012002149 A MX2012002149 A MX 2012002149A MX 2012002149 A MX2012002149 A MX 2012002149A
Authority
MX
Mexico
Prior art keywords
sup
group
nitrogen
treatment
pharmaceutical compositions
Prior art date
Application number
MX2012002149A
Other languages
English (en)
Inventor
Noriaki Takemura
Tsuyoshi Nagase
Kunio Oshima
Shinichi Taira
Kuninori Tai
Yasuhiro Menjo
Takashi Oshiyama
Hokuto Yamabe
Shuuji Matsumura
Masataka Ueda
Yasuo Koga
Sunao Nakayama
Toshiyuki Onogawa
Kenji Tsujimae
Naohiro Isono
Motohiro Itotani
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX2012002149A publication Critical patent/MX2012002149A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención provee un nuevo compuesto de diazepina que bloquea la corriente lKur o el canal Kv1.5 en forma potente y más selectiva que otros canales de K+; la presente invención se refiere a un compuesto de diazepina representado por la Fórmula general (1): (ver fórmula (1)) o una sal del mismo, en donde: R1, R2, R3 y R4 son cada uno independientemente, hidrógeno, alquilo inferior, ciclo alquilo inferior o alcoxi inferior alquilo inferior; R2 y R3 pueden ser ligados para formar alquileno inferior; A1 es alquileno inferior opcionalmente substituido con uno o más substituyentes seleccionados entre el grupo que consiste en hidroxilo y oxo; Y1 e Y2 son cada uno independientemente -N= o -CH=; y R5 es un grupo representado por: (ver fórmula) en donde: R6 y R7 son cada uno independientemente hidrógeno o un grupo orgánico; R6 y R7 pueden ser ligados para formar un anillo junto con el grupo adyacente -XA-N-XB-; XA y XB son cada uno independientemente un enlace, alquileno inferior, etc.
MX2012002149A 2009-08-21 2010-08-20 Compuestos que contienen nitrogeno y composiciones farmaceuticas de los mismos para el tratamiento de fibrilacion auricular. MX2012002149A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23598109P 2009-08-21 2009-08-21
US23597309P 2009-08-21 2009-08-21
US23598309P 2009-08-21 2009-08-21
US35968610P 2010-06-29 2010-06-29
PCT/JP2010/064545 WO2011021726A2 (en) 2009-08-21 2010-08-20 Nitrogen-containing compound and pharmaceutical composition

Publications (1)

Publication Number Publication Date
MX2012002149A true MX2012002149A (es) 2012-03-07

Family

ID=43014533

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002149A MX2012002149A (es) 2009-08-21 2010-08-20 Compuestos que contienen nitrogeno y composiciones farmaceuticas de los mismos para el tratamiento de fibrilacion auricular.

Country Status (24)

Country Link
US (3) US8822453B2 (es)
EP (3) EP2467364B9 (es)
JP (2) JP5769700B2 (es)
KR (1) KR20120081973A (es)
CN (1) CN102482234B (es)
AR (1) AR078098A1 (es)
AU (2) AU2010285621A1 (es)
CA (1) CA2771579A1 (es)
CO (1) CO6440511A2 (es)
DK (1) DK2467364T3 (es)
ES (1) ES2477221T3 (es)
HR (1) HRP20140636T1 (es)
IL (2) IL217101A0 (es)
IN (1) IN2012DN01985A (es)
MX (1) MX2012002149A (es)
NZ (1) NZ598918A (es)
PL (1) PL2467364T3 (es)
PT (1) PT2467364E (es)
RU (1) RU2012110553A (es)
SG (1) SG177316A1 (es)
SI (1) SI2467364T1 (es)
TW (1) TWI481601B (es)
WO (1) WO2011021726A2 (es)
ZA (1) ZA201201025B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120065360A (ko) * 2009-08-21 2012-06-20 오츠카 세이야쿠 가부시키가이샤 벤조［ｂ］［1,4］디아제핀-2,4-디온 화합물의 제조 방법
WO2012162818A1 (en) * 2011-06-03 2012-12-06 Queen's University At Kingston Substituted diarylamines and use of same as antioxidants
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN102627597B (zh) * 2012-04-25 2013-10-23 山东轻工业学院 吲哚-3-甲醛异丁酰腙类衍生物及其制备方法
WO2014184272A2 (en) * 2013-05-14 2014-11-20 Medizinische Hochschule Hannover Means and methods for treating cancer
WO2015051244A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3119397B1 (en) 2014-03-19 2022-03-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN114230571B (zh) 2015-09-14 2025-07-08 无限药品股份有限公司 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
US10759806B2 (en) 2016-03-17 2020-09-01 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) * 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
BE707667A (es) 1966-12-14 1968-06-07
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
GB1460936A (en) * 1974-10-01 1977-01-06 Beecham Group Ltd Benzodiazepines
JPS545981A (en) * 1977-06-10 1979-01-17 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives
IE46852B1 (en) * 1977-06-10 1983-10-05 Otsuka Pharma Co Ltd Novel carbostyril derivatives
JPS54163825A (en) * 1978-06-15 1979-12-26 Otsuka Pharma Co Ltd Phosphoesterase inhibitor
JPS5579372A (en) * 1978-12-08 1980-06-14 Otsuka Pharmaceut Co Ltd Preparation of carbostyril derivative
JPS56122356A (en) 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5780322A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
JPS6010008B2 (ja) * 1982-07-12 1985-03-14 大塚製薬株式会社 血小板凝集抑制剤
JP2753622B2 (ja) * 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
DK391189A (da) * 1988-08-10 1990-02-11 Otsuka Pharma Co Ltd Carbostyrilderivater
JPH0296133A (ja) 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
JPH03148223A (ja) * 1989-11-02 1991-06-25 Otsuka Pharmaceut Co Ltd 血小板凝集抑制剤
BR9200951A (pt) * 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
JPH05194405A (ja) * 1991-08-23 1993-08-03 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体及び血小板凝集抑制剤
AU653060B2 (en) 1991-08-23 1994-09-15 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelet agglutination inhibitor
PE27497A1 (es) 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
TW338037B (en) * 1995-10-05 1998-08-11 Otsuka Pharma Co Ltd Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition
JP2964029B2 (ja) * 1995-10-05 1999-10-18 大塚製薬株式会社 カルボスチリル誘導体
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
AU6895000A (en) * 1999-08-09 2001-03-05 Merck & Co., Inc. Antiarrhythmic compounds
US6949542B2 (en) 2002-02-06 2005-09-27 Hoffman-La Roche Inc. Dihydro-benzo[b][1,4]diazepin-2-one derivatives
US7772433B2 (en) 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
EP1585511B1 (en) * 2002-12-20 2013-01-23 Amgen Inc. Asthma and allergic inflammation modulators
TWI329641B (en) * 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP2007290984A (ja) * 2006-04-21 2007-11-08 Kowa Co コフィリン結合剤、及びコフィリン結合剤を有効成分とする抗癌剤
JP4785881B2 (ja) 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
EP2254873B1 (en) * 2008-02-22 2014-06-04 Otsuka Pharmaceutical Co., Ltd. Benzodiazepine compound and pharmaceutical composition

Also Published As

Publication number Publication date
CA2771579A1 (en) 2011-02-24
IL247086A0 (en) 2016-09-29
TW201111356A (en) 2011-04-01
EP2467364B9 (en) 2015-02-18
IN2012DN01985A (es) 2015-07-24
EP2467364B1 (en) 2014-04-16
CO6440511A2 (es) 2012-05-15
SI2467364T1 (sl) 2014-06-30
US20120225866A1 (en) 2012-09-06
CN102482234B (zh) 2016-04-13
US20140343278A1 (en) 2014-11-20
US20140343277A1 (en) 2014-11-20
AU2016210778A1 (en) 2016-08-25
NZ598918A (en) 2014-03-28
HK1167391A1 (en) 2012-11-30
IL217101A0 (en) 2012-02-29
WO2011021726A2 (en) 2011-02-24
EP2746272A1 (en) 2014-06-25
JP2013502378A (ja) 2013-01-24
SG177316A1 (en) 2012-02-28
AU2010285621A1 (en) 2012-01-12
KR20120081973A (ko) 2012-07-20
US8822453B2 (en) 2014-09-02
HRP20140636T1 (hr) 2014-10-10
JP2015199748A (ja) 2015-11-12
TWI481601B (zh) 2015-04-21
US9212187B2 (en) 2015-12-15
CN102482234A (zh) 2012-05-30
PT2467364E (pt) 2014-07-10
DK2467364T3 (da) 2014-06-30
AR078098A1 (es) 2011-10-12
PL2467364T3 (pl) 2014-12-31
RU2012110553A (ru) 2013-09-27
JP5769700B2 (ja) 2015-08-26
EP2467364A2 (en) 2012-06-27
EP2727917A1 (en) 2014-05-07
ES2477221T3 (es) 2014-07-16
ZA201201025B (en) 2013-05-29
WO2011021726A3 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
MX2012002149A (es) Compuestos que contienen nitrogeno y composiciones farmaceuticas de los mismos para el tratamiento de fibrilacion auricular.
UA103018C2 (uk) Сполуки бензодіазепіну і фармацевтична композиція
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
PH12017501192B1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
MY186165A (en) New bicyclic dihydroquinoline-2-one derivatives
PH12012501589A1 (en) Macrocycles as factor xia inhibitors
IN2012DN01986A (es)
NZ605010A (en) Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MY148636A (en) Benzimidazole derivatives
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
MY169043A (en) New dihydroquinoline-2-one derivatives
PH12012501535A1 (en) Substituted naphthyridines and their use as syk kinase inhibitors
PH12014500814A1 (en) New aryl-quinoline derivatives
WO2014078295A8 (en) Gemcitabine prodrugs and uses thereof
MX348084B (es) Compuestos de cetolido.
MA35086B1 (fr) Compose de triazolopyridine
MX2023002224A (es) Compuestos heterociclicos.
MX378932B (es) Triazoles sustituidos y métodos relacionados a estos.
EA200901391A1 (ru) Пиримидинилпиперазины, применимые в качестве лигандов рецепторов d/d
MX2011007272A (es) Piperidinas de aroilamino y heteroaroilamino sustituidas como inhibidores de glyt-1.
EA201390374A1 (ru) Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина
MX2013013262A (es) Derivados de ciclododecadienona como ingredientes de perfumado.
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
EA201390170A1 (ru) Составы
MX2013005568A (es) Derivado de sulfuro de difenilo y producto farmaceutico que contiene el mismo como ingrediente activo.

Legal Events

Date Code Title Description
FG Grant or registration